Navigation Links
Delaying Parkinson’s Diseas

A new study shows anti-inflammatory drugs do prevent the onset of Parkinson’s disease. The study, led by Harvard researchers, shows people who regularly take nonsteroidal// anti-inflammatory drugs (NSAIDs) had a lower risk of Parkinson’s than those who did not take the drugs.

Parkinson’s disease is characterized by the death of neurons in the brain. The result is a loss in motor function. Some NSAIDs appear to be protective in animal studies and they also are shown to reduce the risk of Alzheimer’s disease in humans. This study looked at the results of two previous studies.

The two studies involved nearly 145,000 men and women. All were free of Parkinson’s disease, stroke, and cancer. About 6 percent of men and nearly 4 percent of women reported regular use of NSAIDs. During the follow-up time period, 415 cases of PD were reported. Participants who reported regular use of NSAIDs at the beginning of the study had about a 45-percent lower risk of developing PD than non-regular users.

In an accompanying editorial, Mya Schiess, M.D., from the University of Texas-Houston Medical School, points out the merits and drawbacks of the study. Dr. Schiess says this study indicates a strong positive benefit of NSAIDs, however it is not yet known what the danger level would be for gastrointestinal bleeding and kidney faiure.
'"/>




Page: 1

Related medicine news :

1. Delaying The Progression Of Alzheimer’s Disease
2. The Effects Of Delaying A Delivery Questioned
3. Delaying pregnancy may lessen life expectancy of the child
4. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
5. Delaying Hernia Surgery Is Considered A Safe Option
6. NPIL withdraws Parkinson’s dru
7. Parkinson’s Drug Linked to Gamblin
8. New Drug For Parkinson’s Disease With Less Side Effect
9. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
10. Magnetic Stimulation For Parkinson’s Diseas
11. Exercising regularly can reduce the risk of Parkinson’s diseas
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: